Clinical Trials and Research

Login or register to access the content restricted to healthcare professionals only


ADVANCED CLINICAL
TRIAL PIPELINE

clinical trial Exact Background Current status Comment
Phase I PK study Bod ECS315 Pharmacokinetics safety and torebility of CBD extract

INITIATED

IN PROGRESS

COMPLETED

Differentiated by Our R & D. this work optimized the design of
our schedule 3 clinical trial
Toxicology Bod ECS315 Safety evaluation of ECS315 For Novel Food registration

INITIATED

IN PROGRESS

COMPLETED

We are 1 of only 6company globally to have secured a validated Novel
Food Application. This is manditory for CBD to sold in the UK and EU
BODOLOS Observational Study Bod ECS315 & Bod ECS100 Real world Evidence on doctors CBD prescribing habits

INITIATED

IN PROGRESS

COMPLETED

Provided important insight into dosing decisions and design of our
schedules 3 clinical trial
CBG pilot study Bod ECS317 Evaluation of the efficiency of a novel CBG compound

INITIATED

IN PROGRESS

COMPLETED

Investigate the effect of CBG on symptoms associated with
fibromyalgia , inflammtory bowel disease and anxiety
Poject chang’e Bod ECS317 & Bod ECS100 Evaluating the combination of different cannabinoids and probiotics
trageting stress, anxiety and inflammtion in animals

INITIATED

IN PROGRESS

data will support furture product launches using combination of CBG
and CBD
phase1 PK study BOD Bio Absorb Pharmacokinetics, safety and tolerability of novel CBD compound

INITIATED

IN PROGRESS

data will support FDA registration and others commercial
opportunities
Phase II insomnia study Bod Bio Absorb using a novel CBD to treat insomania

INITIATED

IN PROGRESS

clinical trial will allow Bod to secure a registration from TGA.
this will allow the product to be sold in Australian Pharmacy’s over
the counter.
Long Covid Study Bod ECS315 Evaluating the efficacy of CBD for symptoms associated with Long
covid

INITIATED

IN PROGRESS

This study provide a unique apportunity to alleviate multiple
symptoms of long covid using one medicine
Emerald Study Phase II study Bod ECS315 The use of CBD in slowing progression of Motor Neuron Disease

INITIATED

IN PROGRESS

Collaboration with Gold Coast University Hospital
Phase I CBN INsomnia study Bod Es310 Using CBN treating primary insomnia

INITIATED

IN PROGRESS

Collaboration with Sydney University & The Woolcock Institute
Project Skin Novel Protein Evaluating the efficancy of a novel protein for inhibiting free
radical damage on skin

INITIATED

IN PROGRESS

At comletion, Bod will own uniqe and novel delivery format of an
anti-aging agent for topical use